Performance History
| Key Stats | |
|---|---|
| Open | $46.78 |
| Prev. Close | $46.93 |
| EPS | -2.16 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $2.86B |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 45.76 | 47.69 |
| 52 Week Range | 13.82 | 47.88 |
| Ratios | |
|---|---|
| P/B Ratio | 6.90 |
| Revenue | $747.71M |
| Operating M. % | -21.74% |
| Earnings | $0.00 |
| Earnings Growth % | -135.33% |
| EBITDA Margin % | -17.48% |
| ROE % | -48.63% |
| EPS | -2.16 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About Tandem Diabetes Care (TNDM)
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. John F. Sheridan
- Headquarters
- San Diego
- Employees
- 2600
- Exchange
- NASDAQ
Keep an eye on Tandem Diabetes Care
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
What is Tandem Diabetes Care 's (TNDM) price per share?
The current price per share for Tandem Diabetes Care (TNDM) is $47.3. The stock has seen a price change of $0.37 recently, indicating a 0.79% change. This reflects the stock's recent market performance and investor sentiment.
What is the 52-week high and low for Tandem Diabetes Care (TNDM)?
For Tandem Diabetes Care (TNDM), the 52-week high is $47.88, which is 1.23% from the current price. The 52-week low is $13.82, the current price is 242.26% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Is Tandem Diabetes Care (TNDM) a growth stock?
Tandem Diabetes Care (TNDM) has shown an average price growth of 0.41% over the past three years. It has received a score of 28 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Tandem Diabetes Care as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
What is Tandem Diabetes Care (TNDM) stock price performance year to date (YTD)?
As of the latest data, Tandem Diabetes Care (TNDM) has a year-to-date price change of 66.96%. Over the past month, the stock has experienced a price change of 48.98%. Over the last three months, the change has been 100.76%. Over the past six months, the figure is 165.88%. Looking at a longer horizon, the five-year price change stands at -29.54%.
Is Tandem Diabetes Care (TNDM) a profitable company?
Tandem Diabetes Care (TNDM) has a net income of -$222.61M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 49.17% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -21.74% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $747.72M, although specific revenue growth data is currently not available. The gross profit is $367.69M. Operating income is noted at -$233.23M. Furthermore, the EBITDA is -$130.71M.
What is the market capitalization of Tandem Diabetes Care (TNDM)?
Tandem Diabetes Care (TNDM) has a market capitalization of $2.87B. The average daily trading volume is 1.41M, indicating the stock's liquidity and investor engagement.
News
Gemini Ultra Training Costs in 2023 Neared $200 Million, More Than 2X GPT4
Microsoft Leads in Carbon Dioxide Removal (CDR) Credit Purchases, Acquiring 6.6M Tonnes, Surpassing All Other Buyers Combined
SoftBank’s Profitability Surges Amid AI Investment Boom
Revolut Hit 26 Million Downloads in 2023, 65% more than a Year Before
US Smartphone Sales to Grow by Only 3% by 2028, 7x Less than in the Chinese Market
Xiaomi and Samsung Smartphones Identified Among Top Radiation Emitters in 2024
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.